Welcome https://www.the-microbiologist.com. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Register
  • Sign In
  • Subscribe
Search our site
Menu
Close menu
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
    • Back to parent navigation item
    • Topics
    • Early Career Research
    • One Health
    • Food Security
    • Climate Action
    • Healthy Land
    • Clean Water
    • Economic Equality
    • Ocean Sustainability
  • Regions
    • Back to parent navigation item
    • Regions
    • Africa & Middle East
    • Asia & Oceania
    • The Americas
    • UK & Europe
    • USA & Canada
  • Videos
  • AMI
    • Back to parent navigation item
    • AMI
    • Community
    • Policy
    • Publishing
    • Events
    • Special Issues
    • Diversity & Inclusion
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
      • Early Career Research
      • One Health
      • Food Security
      • Climate Action
      • Healthy Land
      • Clean Water
      • Economic Equality
      • Ocean Sustainability
  • Regions
      • Africa & Middle East
      • Asia & Oceania
      • The Americas
      • UK & Europe
      • USA & Canada
  • Videos
  • AMI
      • Community
      • Policy
      • Publishing
      • Events
      • Special Issues
      • Diversity & Inclusion
  • More from navigation items

Latest news

Low-Res_画像ソライロラッパムシ_2H2A5640_BC (1)

Corner-loving single-celled microorganism uses geometry to sense its world

2026-04-07T15:43:00+01:00

A surprising observation in the lab has revealed a remarkable ability in Stentor coeruleus, a single-celled organism about one millimeter long. Sometimes nicknamed the “platypus” of microorganisms for its trumpet-like shape, this tiny creature appears to have a distinct preference for corners.

Low-Res_test

Blood test using artificial intelligence paves the way for early diagnosis of leprosy

2026-04-07T15:37:00+01:00

A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. The method showed potential for identifying the disease in its initial stages, when symptoms are subtle and traditional laboratory tests often fail.

Low-Res_frank-loeffler-2048x1092

Bacteria incorporate forever chemicals into cell membrane molecules

2026-04-07T15:20:00+01:00

New research shows that bacteria incorporate polyfluoroalkyl carboxylates—a type of Per- and Polyfluoroalkyl Substances (PFASs)—into the molecules that make up their cell membranes.

pexels-mtk402-9573280

Microscopic coils and coffee trees lead to an amazing new fungal discovery

2026-04-07T15:14:00+01:00

A new study has revealed two novel species of Neohelicomyces fungi: Neohelicomyces coffeae and Neohelicomyces puerensis. While studying the fungi that live on Coffea arabica, researchers spotted these unique organisms growing on dead coffee branches. 

Akulivik_(cropped)

Inuit recommendations to address high rates of tuberculosis in Nunavik, Quebec

2026-04-07T14:58:00+01:00

Tuberculosis rates for Inuit living in Nunavik, the Inuit lands in northern Quebec, are 1,000 times greater than among non-foreign-born Quebeckers, and underresourcing of local health care adds to hardship from the disease, found new research.

Low-Res_Rice_4626_HERO

A new mouse model of virus-driven liver cancer may open the door to better diagnosis and treatments

2026-04-07T14:25:00+01:00

Researchers have created the first mouse model in which chronic viral infection progresses to liver cancer, closely mirroring what happens in people with hepatitis C.

All news content

Research

Low-Res_画像ソライロラッパムシ_2H2A5640_BC (1)

Corner-loving single-celled microorganism uses geometry to sense its world

2026-04-07T15:43:00+01:00

A surprising observation in the lab has revealed a remarkable ability in Stentor coeruleus, a single-celled organism about one millimeter long. Sometimes nicknamed the “platypus” of microorganisms for its trumpet-like shape, this tiny creature appears to have a distinct preference for corners.

Low-Res_frank-loeffler-2048x1092

Bacteria incorporate forever chemicals into cell membrane molecules

2026-04-07T15:20:00+01:00

New research shows that bacteria incorporate polyfluoroalkyl carboxylates—a type of Per- and Polyfluoroalkyl Substances (PFASs)—into the molecules that make up their cell membranes.

pexels-mtk402-9573280

Microscopic coils and coffee trees lead to an amazing new fungal discovery

2026-04-07T15:14:00+01:00

A new study has revealed two novel species of Neohelicomyces fungi: Neohelicomyces coffeae and Neohelicomyces puerensis. While studying the fungi that live on Coffea arabica, researchers spotted these unique organisms growing on dead coffee branches. 

More Research

Industry

Low-Res_mev2

Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment

2026-04-07T09:40:00+01:00

The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.

Laboratory Decontamination (Environment System) (4)

Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI

2026-03-24T12:23:00+00:00

UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.

pexels-kindelmedia-7298675

EnteroBiotix announces completion of enrolment in Phase 2a Trial evaluating EBX-102-02 prior to allogeneic stem cell transplantation

2026-03-10T12:44:00+00:00

EnteroBiotix announced that the investigator-initiated Phase 2a MAST trial has completed its enrolment of 50 adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT) for defined haematological malignancies. 

more industry

Special Issue

Innovation

Low-Res_test

Blood test using artificial intelligence paves the way for early diagnosis of leprosy

2026-04-07T15:37:00+01:00

A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. The method showed potential for identifying the disease in its initial stages, when symptoms are subtle and traditional laboratory tests often fail.

Low-Res_P3130196

Virus-inspired DNA needle could pave the way for better medicines

2026-04-02T15:08:00+01:00

Researchers have developed a microscopic DNA needle that delivers molecules directly into cells and helps keep them active. It may solve a major problem in modern medicine: many therapies are trapped inside cells and lose their effect.

Low-Res_Michael April 1 TB Bacteria Illustration (CDC Image)

Scientists develop therapeutic, nasally delivered DNA vaccine for tuberculosis

2026-04-02T09:39:00+01:00

Research shows the vaccine — in combination with drug therapy — accelerated a relapse-free TB cure in mice, improved activity of a drug-resistant TB regimen and stimulated immune responses in nonhuman primates.

more innovation

People

pexels-charlotte-may-5965674

Global Virus Network launches expanded “Global Guardians for Pandemic Preparedness” program for Florida high school students

2026-04-02T11:45:00+01:00

The Global Virus Network (GVN) announced the launch of its expanded Global Guardians for Pandemic Preparedness initiative, with applications now open for high school students across the state of Florida.

Low-Res_26-04_FUSION-junior-research-group-leaders

Robotics meets genetics: Joining forces to explore Fusarium

2026-04-01T13:54:00+01:00

Two research groups are bringing together two complementary scientific approaches to discover new antifungal agents – targeting Fusarium, but also those derived from Fusarium.

george-prentzas-SRFG7iwktDk-unsplash

Call for evidence: Why has the promise of personalised medicine failed to materialise on the ground?

2026-04-01T00:50:00+01:00

A new inquiry by the UK Parliament’s Science and Technology Committee investigates why the NHS adoption of the UK’s cutting-edge life sciences innovations often fails - and what could be done to fix it. Members of AMI could be just the people to provide answers.

more people

  • Issues
  • Contact us
  • Topics A-Z
  • Writers A-Z
  • Advertise with us
  • Editorial Team
  • In the Loop Newsletter

Bringing the international microbiology community together to advance scientific impact.
appliedmicrobiology.org

© Applied Microbiology International
  • Cookie Policy
  • Privacy
  • Terms of use
  • © 2022 The Microbiologist

Site powered by Webvision Cloud